Assessment of T helper 17-associated cytokines in thromboangiitis obliterans

References

• Fazeli B. Buerger’s disease as an indicator of socioeconomic development in different societies, a cross-sectional descriptive study in the North-East of Iran. Arch Med Sci. 2010;6(3):343–347. doi:10.5114/aoms.2010.1425322371769
   PubMed Web of Science ®Google Scholar
• Fazeli B, Rezaee SA. A review on thromboangiitis obliterans pathophysiology: thrombosis and angiitis, which is to blame? Vascular. 2011;19(3):141–153. doi:10.1258/vasc.2010.ra004521652666
   PubMed Web of Science ®Google Scholar
• Olin JW. Thromboangiitis obliterans : 110 years old and little progress made. J Am Heart Assoc. 2018;7(23):e011214. doi:10.1161/JAHA.118.00852830571606
   PubMed Web of Science ®Google Scholar
• Bajema IM, Bruijn JA, Casian A, et al. The European Vasculitis Society 2016 meeting report. Kidney Int Rep. 2017;2(6):1018–1031. doi:10.1016/j.ekir.2017.06.00729634043
   PubMed Web of Science ®Google Scholar
• Saha K, Chabra N. Treatment of patients with thromboangiitis obliterans with cyclophosphamide. Angiology. 2001;52(6):399–407. doi:10.1177/00033197010520060511437030
   PubMed Web of Science ®Google Scholar
• Fazeli B, Ravari H, Ghazvini K. Rickettsia infection could be the missing piece of the Buerger’s disease puzzle. Int Angiol. 2017;36(5):410–416. doi:10.23736/S0392-9590.17.03420-426344511
   PubMed Web of Science ®Google Scholar
• Mohareri M, Mirhosseini A, Mehraban S, Fazeli B. Thromboangiitis obliterans episode: autoimmune flare-up or reinfection? Vasc Health Risk Manag. 2018;14:247–251. doi:10.2147/VHRM.S12739330319267
   PubMed Web of Science ®Google Scholar
• Zotova NV, Chereshnev VA, Gusev EY. Systemic inflammation: methodological approaches to identification of the common pathological process. PLoS ONE. 2016;11(5):e0155138. doi:10.1371/journal.pone.015513827153324
   PubMed Web of Science ®Google Scholar
• Dellalibera-Joviliano R, Joviliano EE, Silva JS, Evora PR. Activation of cytokines corroborate with development of inflammation and autoimmunity in thromboangiitis obliterans patients. Clin Exp Immunol. 2012;170(1):28–35. doi:10.1111/j.1365-2249.2012.04624.x22943198
   PubMed Web of Science ®Google Scholar
• Slavov ES, Stanilova SA, Petkov DP, Dobreva ZG. Cytokine production in thromboangiitis obliterans patients: new evidence for an immune-mediated inflammatory disorder. Clin Exp Rheumatol. 2005;23(2):219–226.15895893
   PubMed Web of Science ®Google Scholar
• Dellalibera-Joviliano R, Jacob-Ferreira AL, Joviliano EE, Tanus-Santos JE, Evora PR. Imbalanced matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 activities in patients with thromboangiitis obliterans. Vasc Med. 2012;17(2):73–78. doi:10.1177/1358863X1143597922402936
   PubMed Web of Science ®Google Scholar
• Wu S, Sun X, Wu W, Shi D, Jiang T. Effect of revascularization on IL-6 and TNF-α in patients with thromboangiitis obliterans. Exp Ther Med. 2018;15(4):3947–3951. doi:10.3892/etm.2018.587729556267
   PubMed Web of Science ®Google Scholar
• De Caridi G, Bitto A, Massara M, et al. Increased Serum HMGB-1, ICAM-1 and metalloproteinase-9 levels in Buerger’s patients. Curr Vasc Pharmacol. 2016;14(4):382–387.26935815
   PubMed Web of Science ®Google Scholar
• Lee CY, Choi K, Kwon H, et al. Outcomes of endovascular treatment versus bypass surgery for critical limb ischemia in patients with thromboangiitis obliterans. PLoS ONE. 2018;13(10):Oct.
   Web of Science ®Google Scholar
• Peris K, Orlandi A, Ferlosio A, et al. Expression of IL-23/Th17-related cytokines in basal cell carcinoma and in the response to medical treatments. PLoS ONE. 2017;12(8):e0183415. doi:10.1371/journal.pone.018341528829805
   PubMed Web of Science ®Google Scholar
• Xu L, Zhang T, Liu Z, Li Q, Xu Z, Ren T. Critical role of Th17 cells in development of autoimmune hemolytic anemia. Exp Hematol. 2012;40(12):994–1004.e4. doi:10.1016/j.exphem.2012.08.00822960264
   PubMed Web of Science ®Google Scholar
• Yen J-H, Tükel Ç, Rapsinski GJ, et al. Microbial amyloids induce interleukin 17A (IL-17A) and IL-22 responses via toll-like receptor 2 activation in the intestinal mucosa. Infect Immun. 2012;80(12):4398–4408. doi:10.1128/IAI.06224-1123027540
   PubMed Web of Science ®Google Scholar
• Taku K, Fumio I, Motonari K. The role of IL-17 and related cytokines in inflammatory autoimmune diseases. Mediators Inflamm. 2017;20. Epub 2017, Februaty 20. doi:10.1155/2017/3908061
   Web of Science ®Google Scholar
• Maria V, Manuela R. Cytokines IL-17 and IL-22 in the host response to infection. Pathog Dis. 2016;74(9):ftw111. doi:10.1093/femspd/ftw11127915228
   PubMed Web of Science ®Google Scholar
• Shionoya S. Diagnostic criteria of Buerger’s disease. Int J Cardiol. 1998;66(Suppl.1):13. doi:10.1016/S0167-5273(98)00175-2
   Web of Science ®Google Scholar
• World Health Organization. Haemoglobin Concentrations for the Diagnosis of Anaemia and Assessment of Severity. Wordld Health organisation; 2011 Available form: https://apps.who.int/iris/bitstream/handle/10665/85839/WHO_NMH_NHD_MNM_11.1_eng.pdf. Accessed August 8, 2019.
   Google Scholar
• Rosenthal EA, Makaryan V, Burt AA, et al. Association between absolute neutrophil count and variation at TCIRG1: the NHLBI exome sequencing project. Genet Epidemiol. 2016;40(6):470–474. doi:10.1002/gepi.2197627229898
   PubMed Web of Science ®Google Scholar
• Fazeli B, Dadgar Moghadam M, Niroumand S. How to treat a patient with thobliterans: a systematic review. Ann Vasc Surg. 2018;49:219–228. doi:10.1016/j.avsg.2017.10.02229421414
   PubMed Web of Science ®Google Scholar
• Weyand CM, Goronzy JJ. Immune mechanisms in medium and large vessel vasculitis. Nat Rev Rheumatol. 2013;9(12):731–740. doi:10.1038/nrrheum.2013.16124189842
   PubMed Web of Science ®Google Scholar
• Fernandes JR, Berthoud TK, Kumar A, Angel JB. IL-23 signaling in Th17 cells is inhibited by HIV infection and is not restored by HAART: implications for persistent immune activation. PLoS ONE. 2017;12(11):e0186823. doi:10.1371/journal.pone.018682329091911
   PubMed Web of Science ®Google Scholar
• Kagami S, Rizzo HL, Kurtz SE, Miller LS, Blauvelt A. IL-23 and IL-17A, but not IL-12 and IL-22, are required for optimal skin host defense against Candida albicans. J Immunol. 2010;185(9):5453–5462. doi:10.4049/jimmunol.100115320921529
   PubMed Web of Science ®Google Scholar
• Qu N, Xu M, Mizoguchi I, et al. Pivotal roles of T-helper 17-related cytokines, IL-17, IL-22, and IL-23, in inflammatory diseases. Clin Dev Immunol. 2013;2013 Epub 2013, July 14. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728507/pdf/CDI2013-968549.pdf
   Google Scholar
• Sano T, Huang W, Hall JA, et al. An IL-23R/IL-22 circuit regulates epithelial serum amyloid A to promote local effector Th17 responses. Cell. 2015;163(2):381–393. doi:10.1016/j.cell.2015.08.06126411290
   PubMed Web of Science ®Google Scholar
• Schön MP, Erpenbeck L. The interleukin-23/interleukin-17 axis links adaptive and innate immunity in psoriasis. Front Immunol. 2018;9(JUN):1–13. doi:10.3389/fimmu.2018.0132329403488
   PubMed Web of Science ®Google Scholar
• Yang J, Zhang R, Lu G, et al. T cell-derived inducible nitric oxide synthase switches off T H 17 cell differentiation. J Exp Med 2013;210(7):1447–1462.
   Google Scholar
• Nogueira E, Hamour S, Sawant D, et al. Serum IL-17 and IL-23 levels and autoantigen-specific Th17 cells are elevated in patients with ANCA-associated vasculitis. Nephrol Dial Transplant. 2010;25(7):2209–2217. doi:10.1093/ndt/gfp78320100727
   PubMed Web of Science ®Google Scholar
• Abdulahad WH, Lamprecht P, Kallenberg CGM. T-helper cells as new players in ANCA-associated vasculitides. Arthritis Res Ther. 2011;13(4):236. doi:10.1186/ar336221888687
   PubMed Web of Science ®Google Scholar
• McGeachy MJ, Cua DJ, Gaffen SL. The IL-17 family of cytokines in health and disease. Immunity. 2019;50(4):892–906. doi:10.1016/j.immuni.2019.03.02130995505
   PubMed Web of Science ®Google Scholar
• Blake SJ, Teng MWL. Role of IL-17 and IL-22 in autoimmunity and cancer. Actas Dermosifiliogr. 2014;105(Supl1):41–50. doi:10.1016/S0001-7310(14)70017-125398491
   PubMedGoogle Scholar
• Jia L, Wu C. The biology and functions of Th22 cells. Adv Exp Med Biol. 2014;841:209–230. doi:10.1007/978-94-017-9487-9_825261209
   PubMed Web of Science ®Google Scholar
• Schreiber F, Arasteh JM, Lawley TD. Pathogen resistance mediated by IL-22 signaling at the epithelial–microbiota interface. J Mol Biol. 2015;427(23):3676–3682. doi:10.1016/j.jmb.2015.10.01326497621
   PubMed Web of Science ®Google Scholar
• Zenewicz LA, Zenewicz LA. IL-22?: there Is a gap in our knowledge IL-22?: there is a gap in our knowledge. J Immunol 2019;2(6):198–207.
   Google Scholar
• Kolumam G, Wu X, Lee WP, et al. IL-22R ligands IL-20, IL-22, and IL-24 promote wound healing in diabetic db/db mice. PLoS ONE. 2017;12(1):e0170639. doi:10.1371/journal.pone.017063928125663
   PubMed Web of Science ®Google Scholar
• Louis S, Dutertre CA, Vimeux L, et al. IL-23 and IL-12p70 production by monocytes and dendritic cells in primary HIV-1 infection. J Leukoc Biol. 2010;87(4):645–653. doi:10.1189/jlb.100968420097848
   PubMed Web of Science ®Google Scholar
• Smith CL, Arvedson TL, Cooke KS, et al. IL-22 regulates iron availability in vivo through the induction of hepcidin. J Immunol. 2013;191(4):1845–1855. doi:10.4049/jimmunol.120271623836059
   PubMed Web of Science ®Google Scholar
• Sangkhae V, Nemeth E. Regulation of the iron homeostatic hormone hepcidin. Adv Nutr. 2017;8(1):126–136. doi:10.3945/an.116.01396128096133
   PubMed Web of Science ®Google Scholar
• Moyat M, Bouzourene H, Ouyang W, et al. antimicrobial peptides are key determinants of mucosal vaccine-induced protection against H. pylori in mice. Mucosal Immunol. 2017;10(1):271–281. doi:10.1038/mi.2016.3827143303
   PubMed Web of Science ®Google Scholar
• Valeri M, Raffatellu M. Cytokines IL-17 and IL-22 in the host response to infection. Pathog Dis. 2016;74(9):ftw111. doi:10.1093/femspd/ftw11127915228
   PubMed Web of Science ®Google Scholar
• Hu S, He W, Du X, et al. Production of neutrophils enhances antibacteria ability but promotes arthritis development during mycobacterium tuberculosis infection. EBioMedicine. 2017;23:88–99. doi:10.1016/j.ebiom.2017.08.00128821374
   PubMed Web of Science ®Google Scholar
• Ye X, Zhang L, Wang H, Chen Y, Zhang W, Zhu R. The role of IL-23/Th17 pathway in patients with primary immune thrombocytopenia. PLoS ONE. 2015;10(1):e0117704. doi:10.1371/journal.pone.011770425621490
   PubMed Web of Science ®Google Scholar
• Chyuan I, Chen J. Review article role of interleukin- (IL-) 17 in the pathogenesis and targeted therapies in spondyloarthropathies. Mediators Inflamm. 2018;2018:2403935. doi:10.1155/2018/240393529670461
   PubMed Web of Science ®Google Scholar